Decoding androgen receptor inhibitor resistance in prostate cancerSander Palit(The Netherlands Cancer Institute)UnknownApril 12, 202210.33540/1350Cited by 0SaveCiteExport RISWatch citationsRelated PapersTLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth|eLife|2019|38A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer|Scientific Reports|2021|17